Literature DB >> 11684904

Association of the apolipoprotein E epsilon4 allele with late-onset depression.

A S Rigaud1, L Traykov, L Caputo, J Coste, F Latour, R Couderc, F Moulin, F Boller, F Forette.   

Abstract

Apolipoprotein E (ApoE) phenotyping was determined in 42 subjects with Alzheimer's disease (AD), 49 with depression, including 26 with early-onset depression (EOD) and 23 with late-onset depression (LOD), and 49 controls. In the EOD group, the frequency of the ApoE epsilon4 allele was not different from the control frequency (p = 0.532) but was significantly lower than in AD (p < 0.001). In the LOD group, the ApoE epsilon4 frequency was significantly higher than in the controls (p = 0.034) but was not different from that in the AD group (p = 0.229). Individuals with ApoE epsilon4 were at greater risk of getting AD (odds ratio, OR = 5.5, 95% confidence interval, CI, 2.0-14.0) or LOD (OR = 6.1, 95% CI, 1.9-19.0) than of EOD (OR = 0.7, 95% CI, 0.2-2.5). These results suggest an association between the ApoE epsilon4 allele frequency and LOD. Patients with LOD could be at risk of developing AD by an epsilon4-dependent pathway. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684904     DOI: 10.1159/000054801

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  14 in total

1.  Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study.

Authors:  Fumiko Irie; Kamal H Masaki; Helen Petrovitch; Robert D Abbott; G Webster Ross; Dennis R Taaffe; Lenore J Launer; Lon R White
Journal:  Arch Gen Psychiatry       Date:  2008-08

Review 2.  The impact of vascular burden on late-life depression.

Authors:  Micaela Santos; Enikö Kövari; Patrick R Hof; Gabriel Gold; Constantin Bouras; Panteleimon Giannakopoulos
Journal:  Brain Res Rev       Date:  2009-09-08

3.  The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease.

Authors:  A L Pritchard; J Harris; C W Pritchard; J Coates; S Haque; R Holder; P Bentham; C L Lendon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-15       Impact factor: 10.154

4.  Gene-behavior interaction of depressive symptoms and the apolipoprotein E {varepsilon}4 allele on cognitive decline.

Authors:  Kumar B Rajan; Robert S Wilson; Kimberly A Skarupski; Carlos F Mendes de Leon; Denis A Evans
Journal:  Psychosom Med       Date:  2014-01-16       Impact factor: 4.312

5.  Apolipoprotein epsilon4 allele status, depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia.

Authors:  Helen Lavretsky; Linda Ercoli; Prabha Siddarth; Susan Bookheimer; Karen Miller; Gary Small
Journal:  Am J Geriatr Psychiatry       Date:  2003 Nov-Dec       Impact factor: 4.105

6.  Resolving the relationship between ApolipoproteinE and depression.

Authors:  Michael A Slifer; Eden R Martin; John R Gilbert; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Neurosci Lett       Date:  2009-03-06       Impact factor: 3.046

7.  APOE genotype predicts depression in women with Alzheimer's disease: a retrospective study.

Authors:  Lisa Delano-Wood; Wes S Houston; Jennifer A Emond; Natalie L Marchant; David P Salmon; Dilip V Jeste; Leon J Thal; Mark W Bondi
Journal:  Int J Geriatr Psychiatry       Date:  2008-06       Impact factor: 3.485

8.  Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene.

Authors:  Francesco Panza; Davide Seripa; Grazia D'Onofrio; Vincenza Frisardi; Vincenzo Solfrizzi; Patrizia Mecocci; Alberto Pilotto
Journal:  Int J Alzheimers Dis       Date:  2011-04-07

9.  Interactions between the apolipoprotein E ε4 allele status and adverse childhood experiences on depressive symptoms in older adults.

Authors:  Subin Park; Yoon-Young Nam; Yoojin Sim; Jin Pyo Hong
Journal:  Eur J Psychotraumatol       Date:  2015-01-27

10.  The effect of ApoE e4 on blood pressure in patients with and without depression.

Authors:  Knut A Hestad; Knut Engedal; Jon Elling Whist; Per G Farup
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-14       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.